Strontium on comeback for osteoporosis.(Musculoskeletal Disorders) From: Family Practice News | Date: April 1, 2005| Author: Kirn, Timothy F. | COPYRIGHT 2005 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

SAN ANTONIO -- The older generation osteoporosis drug, strontium ranelate, is receiving renewed attention as a result of a metaanalysis showing that it reduces fracture rates in postmenopausal women as well as bisphosphonates do.

Like bisphosphonates, strontium ranelate inhibits bone resorption but also increases bone formation, a combination that improves bone density and bone mass, Jean-Yves Reginster, M.D., said at the annual meeting of the American College of Rheumat...